Escalon Medical Corp.
ESMC · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,675 | $3 | $3 | $3 |
| % Growth | 103,995.9% | -26% | 7.9% | – |
| Cost of Goods Sold | $1,555 | $1 | $2 | $2 |
| Gross Profit | $1,121 | $1 | $2 | $2 |
| % Margin | 41.9% | 43.7% | 46.1% | 48.9% |
| R&D Expenses | $216 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,107 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,323 | $1 | $1 | $1 |
| Operating Income | -$203 | -$0 | $0 | $0 |
| % Margin | -7.6% | -14.5% | 7.9% | 7.9% |
| Other Income/Exp. Net | -$37 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$240 | -$0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$240 | -$0 | $0 | $0 |
| % Margin | -9% | -14.8% | 7.8% | 7.6% |
| EPS | -0.03 | -0.028 | 0.018 | 0.02 |
| % Growth | -8.3% | -251.4% | -8.5% | – |
| EPS Diluted | -0.03 | -0.028 | 0.018 | 0.02 |
| Weighted Avg Shares Out | 7 | 7 | 7 | 7 |
| Weighted Avg Shares Out Dil | 7 | 7 | 14 | 14 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $0 | $0 | $0 |
| Depreciation & Amortization | $8 | $0 | $0 | $0 |
| EBITDA | -$227 | -$0 | $0 | $0 |
| % Margin | -8.5% | -14.1% | 8.2% | 8.1% |